Suchergebnisse - "Alexandre Iannello"

PubPharm (6)

1

Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression

in: Translational Oncology | 2021

von Philip Vitorino | Chen-Hua Chuang | Alexandre Iannello | +7

2

853 ACTM-838: a microbial-based immunotherapy that delivers combination IL-15 + engineered STING to tumor-resident APCs after IV dosing in T-cell excluded solid tumors

in: Journal for ImmunoTherapy of Cancer | 2021

von Laura Glickman | Michele Ardolino | Haixing Kehoe | +9

3

Activating Killer-cell Immunoglobulin-like Receptor genes confer risk for Crohn's disease in children and adults of the Western European descent: Findings based on case-control studies.

in: PLoS ONE | 2019

von Suzanne Samarani | David R Mack | Charles N Bernstein | +7

4

A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells

in: eLife | 2015

von Benjamin G Gowen | Bryan Chim | Caleb D Marceau | +12

5

A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection

enthalten in: Science | 2015

von Jianfeng Xu | Stephanie Lau | Benjamin G Gowen | +7

6

Immunity and tolerance

Erschienen: Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 2013

Cold Spring Harbor symposia on quantitative biology - 78

von O'Garra, A. | Nussenzweig, M. | Smale, S. | +2

1
[1]